Krsnaa Diagnostics plans to acquire a 24% stake in Apulki Healthcare, securing exclusive rights to provide diagnostic services at Apulki’s oncology and cardiology hospitals. This partnership will ensure Krsnaa’s leadership in these segments for over 30 years, offering advanced diagnostic technologies across Apulki’s planned network of hospitals in India.
Related Posts
Top stocks to buy today: Stock recommendations for March 25, 2025
- staff
- March 25, 2025
- 0
Stock market recommendations: RBL Bank and ACC are recommended stocks to buy today by Somil Mehta of Mirae Asset Sharekhan. RBL Bank is anticipated to […]
NPCI ties up with TOI to pitch e-pay safety via R K Laxman’s Common Man
NPCI, in partnership with The Times of India, launches a campaign featuring R K Laxman’s Common Man to enhance digital payment safety awareness. The initiative […]